Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J P Moore

Showing results (41-50 of 269) with videos related to

Pageof 27
Sort By:
Nature Medicine|February 4, 1999
HIV-1 neutralizing antibodies: how full is the bottle?J P Moore, D R Burton
The Journal of Experimental Medicine|July 1, 1995
Human immunodeficiency virus type 1 neutralization is determined by epitope exposure on the gp120 oligomerQ J Sattentau, J P Moore
Nature Medicine|May 19, 1998
Why do we not have an HIV vaccine and how can we make one? D R Burton, J P Moore
The American Surgeon|June 1, 1979
Heterotopic gastric mucosa of the small bowel with perforated ulcerF L Briggs, J P Moore
AIDS (London, England)|January 1, 1991
The role of the V3 loop of gp120 in HIV infectionJ P Moore, P L Nara
Journal of Virology|March 12, 1999
Will multiple coreceptors need to be targeted by inhibitors of human immunodeficiency virus type 1 entry?Y J Zhang, J P Moore
The Journal of Cell Biology|October 19, 2000
HIV-1 membrane fusion: targets of opportunityR W Doms, J P Moore
The Journal of Infectious Diseases|November 14, 1997
Neutralization assays using the BZ167 strain of human immunodeficiency virus type 1J P Moore, D C Montefiori
Lancet (London, England)|August 22, 1992
HIV-negative AIDSJ P Moore, D D Ho
Nature|August 1, 1991
AIDS. Passive primate protectionJ P Moore, R A Weiss
Pageof 27

Showing results (41-50 of 269) with videos related to

Sort By:
Pageof 27
Nature Medicine|February 4, 1999
HIV-1 neutralizing antibodies: how full is the bottle?J P Moore, D R Burton
The Journal of Experimental Medicine|July 1, 1995
Human immunodeficiency virus type 1 neutralization is determined by epitope exposure on the gp120 oligomerQ J Sattentau, J P Moore
Nature Medicine|May 19, 1998
Why do we not have an HIV vaccine and how can we make one? D R Burton, J P Moore
The American Surgeon|June 1, 1979
Heterotopic gastric mucosa of the small bowel with perforated ulcerF L Briggs, J P Moore
AIDS (London, England)|January 1, 1991
The role of the V3 loop of gp120 in HIV infectionJ P Moore, P L Nara
Journal of Virology|March 12, 1999
Will multiple coreceptors need to be targeted by inhibitors of human immunodeficiency virus type 1 entry?Y J Zhang, J P Moore
The Journal of Cell Biology|October 19, 2000
HIV-1 membrane fusion: targets of opportunityR W Doms, J P Moore
The Journal of Infectious Diseases|November 14, 1997
Neutralization assays using the BZ167 strain of human immunodeficiency virus type 1J P Moore, D C Montefiori
Lancet (London, England)|August 22, 1992
HIV-negative AIDSJ P Moore, D D Ho
Nature|August 1, 1991
AIDS. Passive primate protectionJ P Moore, R A Weiss
Pageof 27